There were 110 press releases posted in the last 24 hours and 442,451 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Aligos Therapeutics Presents Positive Clinical Data at Hep-DART 2023 from Phase 1 Studies in HBV (ALG-000184) and NASH (ALG-055009)

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image